Full Professor Tenured
Montreal University
Universite de Montreal
Dr Nicolas Noiseux obtained his MD and MSc degrees in molecular biology at the Université Laval after a Baccalaureate in Biochemistry. Following his training in cardiac surgery at the Université de Montréal, he completed his research fellowship at Harvard University in Boston. He is an independent researcher at the CHUM Research Center and Senior clinician-research scientist scholar from the Fonds de Recherche du Québec en Santé.
Dr Noiseux leads a cutting-edge translational research program and several clinical trials addressing key questions in regenerative and cardiovascular medicine. He has raised sizeable capital in research grants and contracts in basic science and human trials. He is author and co-author of over 170 referred manuscripts in high impact journals, 160 abstracts, over 340 scientific meeting presentations and 90 invited presentations worldwide, and supervises several students at various levels of training. Commissioned Kentucky Colonel by the Governor of the Commonwealth of Kentucky USA in 2018 for outstanding personal and professional achievements. In 2025, he received the King Charles III’s Coronation Medal recipient, for major and continuous contributions to the Heart and Stroke Foundation. He possesses valuable and unique surgical skills in preclinical experimental models mimicking a variety of human diseases in small and large animals. Set up various platforms for in vitro, ex vivo and in vivo experiments to study animals up to humans, at the cellular or whole organ levels. His team is the first in North-America to have developed autologous (patient’s own) stem cell transplantation of a particularly promising cell type (CD133+) to treat heart failure. co-founder and chief medical officer of Targa biomedical (www.targabiomedical.com). Targa’s proprietary technology addresses the universal setbacks of cell therapy/regenerative medicine and organ transplantation with the development of new small molecules.
Disclosure information not submitted.
208 - CLINICAL TRIALS UNVEILED: INVESTIGATOR-INITIATED VS. INDUSTRY-SPONSORED
Friday, October 24, 2025
8:30am - 9:30am ET